Prime Medicine Inc (NAS:PRME)
$ 3.15 +0.070 (+2.27%) Market Cap: 571.34 Mil Enterprise Value: 627.39 Mil PE Ratio: 0 PB Ratio: 0.28 GF Score: 33/100

Prime Medicine Inc at TD Cowen Healthcare Conference Transcript

Mar 4, 2026 / 06:10 PM GMT
Release Date Price: $4.12 (-2.60%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

PRME.OQ - Prime Medicine Inc
Prime Medicine Inc at TD Cowen Healthcare Conference
Mar 04, 2026 / 06:10PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
I Alrighty, well I think we'll go ahead and get started.

Thank you for joining us on day 3 of TD Cowan's 46th annual healthcare conference. I'm Joe Thom, one of the senior biotech analysts here on the team at TD Cowan, and it is my pleasure to have with me today the team from Prime Medicine, and up here with me we have the CEO Alan Ryan. And maybe just to kick things off, before we go into the individual programs, if you want to provide just a brief kind of state of the company overview, recent progress and maybe what should investors be looking at for the rest of 2026.

--------------------------------------------------------------------------------
Unidentified_2 [2]
-------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot